XML 38 R8.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Statement Of Cash Flows [Abstract]    
Net income (loss) $ 718 $ (116)
Adjustments to reconcile net loss to net cash from operating activities:    
Provision for loan losses 150 128
Depreciation 104 122
Amortization, net (7) 134
Net loss on sales of securities 12  
Originations of loans held for sale (28,193) (22,953)
Proceeds from sale of loans held for sale 30,833 23,127
Net gains on sales of loans (293) (149)
Earnings on bank owned life insurance (65) (64)
Stock-based compensation expense 71 149
Net change in:    
Accrued interest receivable and other assets 594 344
Accrued interest payable and other liabilities (325) 1,862
Net cash from operating activities 3,599 2,584
Cash flows from investing activities    
Net (increase) decrease in interest-bearing deposits in other financial institutions   496
Available-for-sale securities:    
Maturities, prepayments and calls 1,280 945
Loan originations and payments, net (30,661) (40,714)
Proceeds from the sale of loans 2,663  
Additions to premises and equipment (18) (414)
Net cash used by investing activities (26,736) (39,687)
Cash flows from financing activities    
Net change in deposits 23,719 34,399
Net change in short-term borrowings from the FHLB and other debt   (1,026)
Proceeds from long-term FHLB advances and other debt 2,500 5,000
Repayments on long-term FHLB advances and other debt (2,500) (7,500)
Net change in advances by borrowers for taxes and insurance (121) (407)
Cash dividends paid on Series B preferred stock (375)  
Net proceeds from issuance of Series B preferred stock   6,358
Net cash from financing activities 23,223 36,824
Net change in cash and cash equivalents 86 (279)
Beginning cash and cash equivalents 28,207 19,160
Ending cash and cash equivalents 28,293 18,881
Supplemental cash flow information:    
Interest paid 1,242 1,102
Supplemental noncash disclosures:    
Loans transferred from held for sale to portfolio 834  
Loans transferred from portfolio to held for sale 175  
Dividends payable on Series B preferred stock $ 187 $ 59